Twist Bioscience Corporation (TWST) Misses Q4 EPS by 4c

Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $99 million versus the consensus estimate of $97.21 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• A. O. Smith CEO Stephen Shafer named chairman
• ZenaTech raises Plurilock Security stake to 12% with new share purchase